University of Pittsburgh Cancer Institute/UPMC – Hillman Cancer Center

 

Cancer prevention and early detection, novel therapeutic discovery, survivorship, and end of life care.

 

UP Cancer Institute/UPMC Cancer Center is a National Cancer Institute-designated comprehensive cancer center internationally recognized for leadership in the prevention, detection, diagnosis, and treatment of cancer, especially with regard to molecular and medical oncology. The twin institution forms the hub of a network of more than 40 treatment centers in Pennsylvania, Ohio and Ireland. It relies heavily on innovative technologies that allow for precise tumor imaging and radiation treatment delivery. These include modulated radiation therapy, RapidArc, TrueBeam STx, CyberKnife M6, and PET–CT. Much research occurs here: since 2009, the center’s scientists published 4,500 research articles. Current research goals include expanding the breadth and depth of knowledge concerning the biological basis of cancer development and progression, identifying new and relevant biomarkers for improved cancer detection and diagnosis, developing novel therapeutics for successful and comprehensive cancer treatment, and establishing and implementing effective measures for cancer prevention.